Her primary areas of study are Multiple sclerosis, Internal medicine, Central nervous system disease, Atrophy and Surgery. Bianca Weinstock-Guttman specializes in Multiple sclerosis, namely Interferon beta-1a. The study incorporates disciplines such as Gastroenterology, Immunology, Expanded Disability Status Scale and Cardiology in addition to Internal medicine.
Her Central nervous system disease research is multidisciplinary, incorporating perspectives in Demyelinating disease, Central nervous system, Socioeconomic status and Neuromyelitis optica. Her Atrophy study also includes fields such as
Her scientific interests lie mostly in Multiple sclerosis, Internal medicine, Atrophy, Pathology and Magnetic resonance imaging. Bianca Weinstock-Guttman combines subjects such as Lesion and Cognition with her study of Multiple sclerosis. Bianca Weinstock-Guttman has researched Cognition in several fields, including Clinical psychology, Physical medicine and rehabilitation and Audiology.
Within one scientific family, she focuses on topics pertaining to Cardiology under Internal medicine, and may sometimes address concerns connected to Chronic cerebrospinal venous insufficiency. Her study on Atrophy also encompasses disciplines like
Bianca Weinstock-Guttman mainly investigates Multiple sclerosis, Internal medicine, Atrophy, Cognition and In patient. Her Multiple sclerosis research focuses on Expanded Disability Status Scale in particular. Her study looks at the relationship between Internal medicine and topics such as Fingolimod, which overlap with Natalizumab.
Her research on Atrophy also deals with topics like
Her primary scientific interests are in Multiple sclerosis, Internal medicine, Atrophy, Cognition and Clinically isolated syndrome. She conducts interdisciplinary study in the fields of Multiple sclerosis and In patient through her research. Her Internal medicine research is multidisciplinary, incorporating perspectives in Oncology, Cardiology, Expanded Disability Status Scale, Fingolimod and Magnetic resonance imaging.
Her studies examine the connections between Atrophy and genetics, as well as such issues in Brain size, with regards to Putamen, Disease onset and Healthy individuals. The various areas that Bianca Weinstock-Guttman examines in her Cognition study include Physical medicine and rehabilitation, Audiology and Cognitive decline. The concepts of her Clinically isolated syndrome study are interwoven with issues in Congenital cytomegalovirus infection, Logistic regression, Retrospective cohort study and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
Lawrence D. Jacobs;Diane L. Cookfair;Richard A. Rudick;Robert M. Herndon.
Annals of Neurology (1996)
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Richard A. Rudick;William H. Stuart;Peter A. Calabresi;Christian Confavreux.
The New England Journal of Medicine (2006)
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
Ralph H.B. Benedict;Diane Cookfair;Rebecca Gavett;Mark Gunther.
Journal of The International Neuropsychological Society (2006)
Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.
Ralph H.B. Benedict;Elizabeth Wahlig;Rohit Bakshi;Inna Fishman.
Journal of the Neurological Sciences (2005)
Thalamic atrophy and cognition in multiple sclerosis
M. K. Houtchens;R.H.B. Benedict;R. Killiany;J. Sharma.
Neurology (2007)
Prediction of Neuropsychological Impairment in Multiple Sclerosis Comparison of Conventional Magnetic Resonance Imaging Measures of Atrophy and Lesion Burden
Ralph H. B. Benedict;Bianca Weinstock-Guttman;Inna Fishman;Jitendra Sharma.
JAMA Neurology (2004)
Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis
Jack H. Simon;Lawrence D. Jacobs;Marilyn Campion;Karl Wende.
Annals of Neurology (1998)
Eight-year follow-up study of brain atrophy in patients with MS
E. Fisher;R. A. Rudick;J. H. Simon;G. Cutter.
Neurology (2002)
Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis
Ralph H. B. Benedict;Jared M. Bruce;Michael G. Dwyer;Nadir Abdelrahman.
JAMA Neurology (2006)
The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL
P. A. Calabresi;G. Giovannoni;C. Confavreux;S. L. Galetta.
Neurology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University at Buffalo, State University of New York
University at Buffalo, State University of New York
University at Buffalo, State University of New York
Harvard University
Mayo Clinic
University of California, San Francisco
Stony Brook University
Biogen (United States)
Charles University
Brigham and Women's Hospital
French Institute for Research in Computer Science and Automation - INRIA
Osaka University
National Institute of Technology Tiruchirappalli
Mondial Advisory
Carnegie Mellon University
University of Cambridge
The Ohio State University
San Diego State University
University of Pretoria
Brandeis University
Catholic University of the Sacred Heart
Jilin University
McGill University
Arizona State University
Michigan State University
Yale University